Centene (CNC) Competitors $59.75 -0.31 (-0.52%) (As of 01:22 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUEShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry. Centene vs. Elevance Health The Cigna Group Humana Molina Healthcare UnitedHealth Group Oscar Health Alignment Healthcare Trupanion Clover Health Investments NeueHealth Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk. Which has better earnings & valuation, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$154.00B0.20$2.70B$5.7610.43Elevance Health$171.34B0.56$5.99B$27.4314.96 Do analysts rate CNC or ELV? Centene currently has a consensus price target of $83.92, indicating a potential upside of 39.73%. Elevance Health has a consensus price target of $539.20, indicating a potential upside of 31.39%. Given Centene's higher probable upside, equities analysts clearly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50Elevance Health 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.81 Is CNC or ELV more profitable? Elevance Health has a net margin of 3.68% compared to Centene's net margin of 1.90%. Elevance Health's return on equity of 19.56% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene1.90% 13.32% 4.32% Elevance Health 3.68%19.56%7.22% Does the MarketBeat Community believe in CNC or ELV? Centene received 180 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.40% of users gave Centene an outperform vote while only 67.26% of users gave Elevance Health an outperform vote. CompanyUnderperformOutperformCenteneOutperform Votes104373.40% Underperform Votes37826.60% Elevance HealthOutperform Votes86367.26% Underperform Votes42032.74% Does the media prefer CNC or ELV? In the previous week, Elevance Health had 10 more articles in the media than Centene. MarketBeat recorded 29 mentions for Elevance Health and 19 mentions for Centene. Elevance Health's average media sentiment score of 1.43 beat Centene's score of 1.23 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 17 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 24 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, CNC or ELV? Centene has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Do insiders and institutionals have more ownership in CNC or ELV? 93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.3% of Centene shares are owned by insiders. Comparatively, 0.4% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryElevance Health beats Centene on 15 of the 19 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$30.32B$70.24B$5.31B$20.36BDividend YieldN/A1.46%5.23%3.45%P/E Ratio10.4323.02136.9744.58Price / Sales0.200.671,455.4620.33Price / Cash6.499.6541.6722.41Price / Book1.115.427.334.76Net Income$2.70B$3.04B$117.74M$984.70M7 Day Performance0.10%2.31%3.38%0.64%1 Month Performance-5.45%-0.61%2.50%6.66%1 Year Performance-19.79%41.69%35.96%24.58% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9775 of 5 stars$59.75-0.5%$83.92+40.5%-19.8%$30.17B$161.73B10.3767,700Positive NewsELVElevance Health4.8994 of 5 stars$411.54+1.1%$539.20+31.0%-15.1%$95.44B$171.34B14.84104,900Short Interest ↑Positive NewsCIThe Cigna Group4.9655 of 5 stars$337.80flat$394.64+16.8%+25.3%$93.96B$195.27B31.8772,500Positive NewsHUMHumana4.3176 of 5 stars$294.07-0.8%$315.86+7.4%-40.8%$35.41B$106.37B26.2567,600MOHMolina Healthcare4.5759 of 5 stars$300.85+1.0%$367.17+22.0%-16.8%$17.21B$34.07B15.19123,123Positive NewsUNHUnitedHealth Group4.8875 of 5 stars$606.94-0.5%$618.26+1.9%+11.2%$558.55B$371.62B39.75440,000Analyst ForecastPositive NewsOSCROscar Health2.2482 of 5 stars$18.05+4.2%$22.93+27.0%+119.1%$4.46B$8.22B-306.832,400Positive NewsALHCAlignment Healthcare1.6805 of 5 stars$12.49-1.0%$10.33-17.3%+74.5%$2.39B$2.47B-16.361,536Analyst UpgradeShort Interest ↓Gap UpTRUPTrupanion1.7944 of 5 stars$52.50-1.5%$44.67-14.9%+82.7%$2.22B$1.11B-166.591,142Insider TradeCLOVClover Health Investments2.0831 of 5 stars$3.43-1.4%$4.00+16.6%+261.1%$1.72B$2.12B-17.40552Short Interest ↓Positive NewsNEUENeueHealth3.2921 of 5 stars$4.90-3.0%$8.00+63.3%N/A$40.57M$1.16B-0.101,252Gap Up Related Companies and Tools Related Companies ELV Alternatives CI Alternatives HUM Alternatives MOH Alternatives UNH Alternatives OSCR Alternatives ALHC Alternatives TRUP Alternatives CLOV Alternatives NEUE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNC) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.